WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007077339) INTERFERING RNAS TARGETING THE MORBILLIVIRUS NUCLEOPROTEIN GENE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2007/077339 International Application No.: PCT/FR2006/002819
Publication Date: 12.07.2007 International Filing Date: 21.12.2006
IPC:
C12N 15/11 (2006.01) ,A61K 31/7105 (2006.01)
Applicants: ALBINA, Emmanuel[FR/FR]; FR (UsOnly)
LIBEAU, Geneviève[FR/FR]; FR (UsOnly)
KEITA, Djénéba[CI/FR]; FR (UsOnly)
SERVAN DE ALMEIDA, Renata[BR/FR]; FR (UsOnly)
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LE DEVELOPPEMENT (CIRAD)[FR/FR]; 42, Rue Scheffer F-75016 Paris, FR (AllExceptUS)
Inventors: ALBINA, Emmanuel; FR
LIBEAU, Geneviève; FR
KEITA, Djénéba; FR
SERVAN DE ALMEIDA, Renata; FR
Agent: VIALLE-PRESLES, Marie-José ; CABINET ORES 36, Rue De Saint-pétersbourg F-75008 Paris, FR
Priority Data:
05/1302921.12.2005FR
06/0940026.10.2006FR
Title (EN) INTERFERING RNAS TARGETING THE MORBILLIVIRUS NUCLEOPROTEIN GENE
(FR) ARN INTERFERENTS CIBLANT LE GENE DE LA NUCLEOPROTEINE DE MORBILLIVIRUS
Abstract:
(EN) The invention relates to interfering RNAs (siRNAs, shRNAs or pre-miRNAs) directed against conserved regions of the mRNA of the N gene encoding the morbillivirus nucleoprotein. The invention also relates to the use of said interfering RNAs for the production of medicaments for use in the treatment or prevention of a morbillivirus infection.
(FR) L'invention est relative à des ARN interférents (siARN, shARN ou pré-miARN) dirigés contre des régions conservées de l'ARNm du gène N codant pour la nucléoprotéine de morbillivirus. L'invention est également relative à l'utilisation desdits ARN interférents pour l'obtention de médicaments destinés au traitement ou à la prévention d'une infection à morbillivirus.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)